| Value | ₹221.0 Cr |
|---|---|
| Execution period | 18 months |
BSE filing, BSE: 544037. Summary written from the filing by ALFA Finder's alert engine.
AMIC Forging Ltd: key numbers
- Share price
- ₹2,044.50
- Market cap
- ₹2,144 Cr
- Revenue (annual)
- ₹141.8 Cr
- Net profit (annual)
- ₹28.27 Cr
- P/E (TTM)
- 75.8×Sector 51.5×
- Promoter holding
- 55.11%
- FII holding
- 0.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AMIC Forging Ltd
All →AMIC Forging Other Announcement
Amic Forging Ltd submitted its quarterly shareholding pattern as per Regulation 31(1)(b) of the SEBI LODR Regulations. No material business or financial event occurred.
AMIC Forging Annual General Meeting
Amic Forging Ltd held its 19th Annual General Meeting on September 30, 2026. The meeting discussed the adoption of financial statements and director re-appointments.
AMIC Forging Annual General Meeting
Amic Forging Ltd issued the notice for its 19th AGM on September 30, 2026. Resolutions cover FY26 financials, director re-appointment, and MD remuneration increase.
AMIC Forging Board Meeting Outcome
Amic Forging Ltd. announced the re-appointment of its internal and cost auditors for the financial year 2026-27 following a board meeting.
AMIC Forging Capital Structure Change
Amic Forging allotted 26,200 equity shares and 14.22 lakh warrants on a preferential basis. The total issuance value aggregates to approximately Rs. 220.99 Crore.
- Value
- ₹221.0 Cr
AMIC Forging Results Correction
Amic Forging Ltd submitted a revised audit report correcting prior discrepancies. FY‑2026 revenue stands at ₹141.78 Cr.
- Value
- ₹141.8 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.